208 related articles for article (PubMed ID: 37025083)
1. Dronedarone versus sotalol in patients with atrial fibrillation: A systematic literature review and network meta-analysis.
Singh JP; Blomström-Lundqvist C; Turakhia MP; Camm AJ; Fazeli MS; Kreidieh B; Crotty C; Kowey PR
Clin Cardiol; 2023 Jun; 46(6):589-597. PubMed ID: 37025083
[TBL] [Abstract][Full Text] [Related]
2. Dronedarone Versus Sotalol in Antiarrhythmic Drug-Naive Veterans With Atrial Fibrillation.
Pundi K; Fan J; Kabadi S; Din N; Blomström-Lundqvist C; Camm AJ; Kowey P; Singh JP; Rashkin J; Wieloch M; Turakhia MP; Sandhu AT
Circ Arrhythm Electrophysiol; 2023 Aug; 16(8):456-467. PubMed ID: 37485722
[TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
Valembois L; Audureau E; Takeda A; Jarzebowski W; Belmin J; Lafuente-Lafuente C
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD005049. PubMed ID: 31483500
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of dronedarone in patients previously treated with other antiarrhythmic agents.
Guerra F; Hohnloser SH; Kowey PR; Crijns HJ; Aliot EM; Radzik D; Roy D; Connolly S; Capucci A
Clin Cardiol; 2014 Dec; 37(12):717-24. PubMed ID: 25470298
[TBL] [Abstract][Full Text] [Related]
5. Ventricular arrhythmia and death among atrial fibrillation patients using anti-arrhythmic drugs.
Friberg L
Am Heart J; 2018 Nov; 205():118-127. PubMed ID: 30236980
[TBL] [Abstract][Full Text] [Related]
6. International cohort study on the effectiveness of dronedarone and other antiarrhythmic drugs for atrial fibrillation in real-world practice (EFFECT-AF).
Khachatryan A; Merino JL; de Abajo FJ; Botto GL; Kirchhof P; Breithardt G; Stambler B; Abenhaim L; Grimaldi-Bensouda L
Europace; 2022 Jul; 24(6):899-909. PubMed ID: 34792111
[TBL] [Abstract][Full Text] [Related]
7. The effect of antiarrhythmic medications on the risk of cardiovascular outcomes in patients with atrial fibrillation and coronary artery disease.
Wang SR; Huang KC; Lin TT; Chuang SL; Yang YY; Wu CK; Lin LY
Int J Cardiol; 2024 Aug; 409():132198. PubMed ID: 38782070
[TBL] [Abstract][Full Text] [Related]
8. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
Maund E; McKenna C; Sarowar M; Fox D; Stevenson M; Pepper C; Palmer S; Woolacott N
Health Technol Assess; 2010 Oct; 14(Suppl. 2):55-62. PubMed ID: 21047492
[TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
Lafuente-Lafuente C; Valembois L; Bergmann JF; Belmin J
Cochrane Database Syst Rev; 2015 Mar; (3):CD005049. PubMed ID: 25820938
[TBL] [Abstract][Full Text] [Related]
10. Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation.
Wharton JM; Piccini JP; Koren A; Huse S; Ronk CJ
J Am Heart Assoc; 2022 Feb; 11(3):e020506. PubMed ID: 35060388
[TBL] [Abstract][Full Text] [Related]
11. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation.
Qin D; Leef G; Alam MB; Rattan R; Munir MB; Patel D; Khattak F; Adelstein E; Jain SK; Saba S
J Cardiol; 2016 May; 67(5):471-6. PubMed ID: 26233885
[TBL] [Abstract][Full Text] [Related]
13. Pre-treatment with antiarrhythmic drugs for elective electrical cardioversion of atrial fibrillation: a systematic review and network meta-analysis.
Um KJ; McIntyre WF; Mendoza PA; Ibrahim O; Nguyen ST; Lin SH; Duceppe E; Rochwerg B; Healey JS; Koziarz A; Lengyel AP; Bhatnagar A; Amit G; Chu VA; Whitlock RP; Belley-Côté EP
Europace; 2022 Oct; 24(10):1548-1559. PubMed ID: 35654763
[TBL] [Abstract][Full Text] [Related]
14. Dronedarone for the treatment of atrial fibrillation: a NICE single technology appraisal.
McKenna C; Maund E; Sarowar M; Fox D; Stevenson M; Pepper C; Woolacott N; Palmer S
Pharmacoeconomics; 2012 Jan; 30(1):35-46. PubMed ID: 22136303
[TBL] [Abstract][Full Text] [Related]
15. Comparison of dronedarone vs. flecainide in the maintenance of sinus rhythm, following electrocardioversion in adults with persistent atrial fibrillation: a systematic review and meta-analysis.
Wilson H; Patton D; Moore Z; O'Connor T; Nugent L
Eur Heart J Cardiovasc Pharmacother; 2021 Sep; 7(5):363-372. PubMed ID: 32163173
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Switch From Amiodarone to Dronedarone in Patients With Atrial Fibrillation: Results of the ARTEMIS AF Studies.
Naccarelli GV; Bhatt DL; Camm AJ; Le Heuzey JY; Lombardi F; Tamargo J; Martinez JM; Naditch-Brûlé L;
J Cardiovasc Pharmacol Ther; 2020 Sep; 25(5):425-437. PubMed ID: 32500725
[TBL] [Abstract][Full Text] [Related]
17. Dronedarone: a promising alternative for the management of atrial fibrillation.
Yalta K; Turgut OO; Yilmaz MB; Yilmaz A; Tandogan I
Cardiovasc Drugs Ther; 2009 Oct; 23(5):385-93. PubMed ID: 19669399
[TBL] [Abstract][Full Text] [Related]
18. Assessing the Risk for Peripheral Neuropathy in Patients Treated With Dronedarone Compared With That in Other Antiarrhythmics.
Wu C; Tcherny-Lessenot S; Dai W; Wang Y; Kechemir H; Gandhi S; Lin S; Juhaeri J
Clin Ther; 2018 Mar; 40(3):450-455.e1. PubMed ID: 29500139
[TBL] [Abstract][Full Text] [Related]
19. Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials.
Thind M; Crijns HJ; Naccarelli GV; Reiffel JA; Corp Dit Genti V; Wieloch M; Koren A; Kowey PR
J Cardiovasc Electrophysiol; 2020 May; 31(5):1022-1030. PubMed ID: 32083368
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants.
Wu VC; Wang CL; Huang YC; Tu HT; Huang YT; Huang CH; Chen SW; Kuo CF; Hung KC; Chang SH
Europace; 2023 May; 25(5):. PubMed ID: 37000581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
